1 / 23

What Schering-Plough Biopharma?

What Schering-Plough Biopharma?. Pharmaceutical Company What kind of research is performed at the facility?. What Schering-Plough Biopharma?. Pharmaceutical Company What kind of research is performed at the facility? Is there a conflict of interest?

justus
Télécharger la présentation

What Schering-Plough Biopharma?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. What Schering-Plough Biopharma? • Pharmaceutical Company • What kind of research is performed at the facility?

  2. What Schering-Plough Biopharma? • Pharmaceutical Company • What kind of research is performed at the facility? • Is there a conflict of interest? • They all work for Schering-Plough Biopharma • Merged with Merck in 2009

  3. What is an Autoimmune disease? • Is defined as an immune response against self antigens. • What are some of the major autoimmune diseases? -Crohn’s Disease -Lupus -Scleroderma • - Rheumatoid arthritis • - Multiple Sclerosis • - Totaling about 50

  4. Symptoms

  5. Multiple Sclerosis Progressive-relapsing • Two major classes • Relapsing • 85-90% start this way • 65% remain • Progressive • 10-15% Primary • 20-25% Secondary Secondary Progressive Primary Progressive Relapsing-Remitting http://upload.wikimedia.org/wikipedia/commons/3/3c/Ms_progression_types.svg

  6. Environmental Factors • More common in people that live farther from the equator • Sunlight link to MS risk (Vitamin D) – Related? • Virus connection? (HHV-6 and EBV)

  7. Environmental Factor Per 100,000 individuals in the population

  8. What are the different genetic factors? • Human leukocyte antigen (HLA) system • Genes that serve as the major histocompatibility complex (MHC) What is a MHC?

  9. MHC I and II • MHC I • All nucleated cells • Three polymorphic classes • 6 possible combinations in the population • How many can you have? • MHC II • Mainly dendritic cells, macrophages, and B lymphocytes • A heterozygote can inherit six or eight alleles • These are one DQ and DP and one or two DR’s

  10. MHC II

  11. MHC II Peptide-binding cleft α1 β1 • There are two alleles associated with MS • DR15 • DQ6 • There are two protective alleles • HLA-C554 • HLA-DRB1*11 α2 β2 membrane

  12. MHC II and T cell Interaction T cell Macrophage

  13. T cells or lymphocytes • Four classes • Cytotoxic, Regulatory, Memory, Helper • T-helper cells (TH cells) • Secrete small proteins (cytokines, interleukins) • Several subtypes to create unique immune response • This differentiation is unknown, but believed to be through the MHC and peptide sequence recognition

  14. Interleukins • A group of cytokines released by lymphocytes • Most are produced in CD4+ cells • They are believe to promote differentiation • The paper mentions • 4, 6, 10, 17, 22, 23, 25, 27 • However, the large focus is on • 6, 10, 17, 23

  15. So, what is so bad about Interleukin 17? • Myelinated Schwann Cells • Composed of 80% lipid and 20% protein • Myelin Basic Protein, Myelin oligodendrocyte glycoprotein, and? • Proteolipid Protein • May assist in compaction, stabilization, and maintenance of myelin sheaths http://www.google.com/imgres?imgurl=http://www.signaling-gateway.org/update/images/updates_thumbs/nri2325.jpg&imgrefurl=http://www.signaling-gateway.org/update/updates/200805/index.html&usg=__CDzMs7VIzAxllHFTQG85ytleaWY=&h=80&w=80&sz=3&hl=en&start=13&um=1&itbs=1&tbnid=PXKQovmvAyZWWM:&tbnh=74&tbnw=74&prev=/images%3Fq%3Dinterleukin%2B17%26um%3D1%26hl%3Den%26sa%3DN%26tbs%3Disch:1

  16. Cell Body Dendrites Axon Myelin Sheath Axon Myelinated Schwann Cell Proteolipid Protein

  17. Now what happens in MS • Proteolipid Protein • TH-17 cells • Axon • Myelin

  18. Now what happens in MS • Proteolipid Protein • TH-17 cells

  19. Why is this bad? • Sodium Channels along axon are exposed (lose Nodes of Ranvier) • Demyelination causes a loss of action potential in the cell. • Neurons cannot send signals or signals are sent at a very slow rate

  20. Other information you may need to know • Experimental Autoimmune Encephalomyelitis • EAE model • Equivalent model in mice • Transforming growth factor Beta (TGF-β) • Development of TH-17 cells • Development of Regulatory T cells • Blocks the activation of lymphocytes and monocytes

  21. Where are we going? • The paper wants to show if TGF-β promotes pathogenic function of TH-17 cells • Or, does the immunoregulatory effects of TGF-β play in TH-17 cells sensitivity and suppression • Here, they look at responses of activated myelin-reactive T cells with treatments of IL-23 or TGF-β and IL-6

  22. References McGeachy, M. J., K. S. Bak-Jensen, Y. Chen, C. M. Tato, W. Blumenschein, T. McClanahan, and D. J. Cua. 2007. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated patholgy. Nature Immuno. 8: 1390-97. Langrish, C. L. et al. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240. Abbas, A. K. and A. H. Litchman. 2006. Basic Immunology: 3rd edition. Saunders. Victor, M., Ropper, A. H., and R. D. Adams. 2000. Adams & Victor’s Principles of Neurology: 7th Edition. McGraw-Hill Professional.

More Related